Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes (2023)
- Authors:
- USP affiliated authors: GIDLUND, MAGNUS AKE - ICB ; FONSECA, HENRIQUE ANDRADE RODRIGUES DA - ICB
- Unidade: ICB
- DOI: 10.1016/j.ejim.2023.07.018
- Subjects: IMUNOLOGIA; AUTOANTICORPOS; APOLIPOPROTEÍNAS; EPITOPOS; DIABETES MELLITUS; DOENÇAS CARDIOVASCULARES; LIPOPROTEÍNAS LDL
- Language: Inglês
- Imprenta:
- Publisher: Elsevier BV
- Publisher place: Amsterdam
- Date published: 2023
- Source:
- Título: European Journal of Internal Medicine
- ISSN: 1879-0828
- Volume/Número/Paginação/Ano: v. 116, p. 152-154, 2023
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SANT´ANNA, Viviane Aparecida Rodrigues et al. Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes. European Journal of Internal Medicine. Amsterdam: Elsevier BV. Disponível em: https://doi.org/10.1016/j.ejim.2023.07.018. Acesso em: 09 jan. 2026. , 2023 -
APA
Sant´Anna, V. A. R., Izar, M. C. O., Fonseca, H. A. R. da, & Gidlund, M. A. (2023). Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes. European Journal of Internal Medicine. Amsterdam: Elsevier BV. doi:10.1016/j.ejim.2023.07.018 -
NLM
Sant´Anna VAR, Izar MCO, Fonseca HAR da, Gidlund MA. Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes [Internet]. European Journal of Internal Medicine. 2023 ; 116 152-154.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1016/j.ejim.2023.07.018 -
Vancouver
Sant´Anna VAR, Izar MCO, Fonseca HAR da, Gidlund MA. Autoantibodies against an immunodominant epitope from apolipoprotein B and risk of cardiovascular events in subjects with type 2 diabetes [Internet]. European Journal of Internal Medicine. 2023 ; 116 152-154.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1016/j.ejim.2023.07.018 - Circulation of natural autoantibodies against an immunodominant region of the apolipoprotein B after an acute coronary syndrome: a prospective observational study
- Immunometabolic and vascular health responses among high endurance trained subjects
- Opposing effects between short-term combined transdermal estradiol/noretisterone against oxidized LDL (oxLDL) and heat shock proteins (hsp)
- M pneumoniae infection, pulmonary thromboembolism and antiphospholipid antibodies
- Establishment of a hamster model for evaluation of cardiocytotoxic drugs
- Increased atherosclerosis markers are associated with higher activities of phospholipid or cholesteryl ester transfer proteins in adults with high hdl-cholesterol
- Investigação sobre o papel do quilomícron natural na aterosclerose: captação de emulsões ricas em triaciglicerol pelos macrófagos é facilitada pela co-incubação com LDL nativa e modificada
- High resolution separation of low density lipoprotein (LDL) and LDL with high or low degree of oxidation (OXLDL) and evaluation of their rectivity against autoantibodies
- Freund's incomple adjuvant does not influence parameters involved in atherosclerosis development in the ApoE-/- mouse experimental model
- Fragmentos deapolipoproteína-B gerados por oxidação (MLDL) é o principal alvo para formação de autoanticorpos na aterosclerose
Informações sobre o DOI: 10.1016/j.ejim.2023.07.018 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
